Bajaj Healthcare Reports Mixed Financial Results Amidst Sector Challenges in March 2025

Jul 28 2025 07:47 PM IST
share
Share Via
Bajaj Healthcare's financial results for the quarter ending March 2025 highlight a mixed performance in the Pharmaceuticals & Biotechnology sector. While Profit After Tax increased to Rs 30.22 crore, net sales reached a five-quarter high at Rs 154.47 crore. However, challenges include a decline in Profit Before Tax and operating profit margin.
Bajaj Healthcare has recently reported its financial results for the quarter ending March 2025, revealing a complex picture of performance within the Pharmaceuticals & Biotechnology sector. The company has experienced notable shifts in its evaluation, with a revision in its score reflecting the current financial landscape.

On a positive note, Bajaj Healthcare's Profit After Tax (PAT) for the latest six months stands at Rs 30.22 crore, showcasing a year-on-year growth of 34.20%. This indicates a favorable trend in profitability in the near term. Additionally, net sales reached Rs 154.47 crore, marking the highest figure in the last five quarters, suggesting a robust sales performance.

Conversely, several challenges are evident in the financial results. The Profit Before Tax less Other Income (PBT) has shown a significant decline, recorded at Rs -1.43 crore, which represents a substantial year-on-year decrease. Furthermore, the operating profit margin has fallen to 7.61%, the lowest in recent quarters, indicating a decline in operational efficiency. The company's ability to manage interest payments has also come under pressure, with the operating profit to interest ratio at its lowest point in five quarters.

Overall, Bajaj Healthcare's financial results reflect a mix of positive growth in certain areas alongside significant challenges that warrant attention.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News